Sign inGet started

O'Farrell Elizabeth G.

Insider CIK 1744662 · LNSR Director · IKT Director · SGP Director · PDLI Director · GERN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LNSR LENSAR, Inc. A Award2026-06-032026-06-0517,421— $067,368SEC↗
GERN GERON CORP A Award deriv2026-05-202026-05-26220,000— $0220,000SEC↗
SGP SpyGlass Pharma, Inc. A Award deriv2026-02-052026-02-0913,700— $013,700SEC↗
LNSR LENSAR, Inc. A Award2025-05-232025-05-287,374— $049,947SEC↗
GERN GERON CORP A Award deriv2025-05-212025-05-22180,000— $0180,000SEC↗
GERN GERON CORP A Award deriv2024-05-092024-05-10180,000— $0180,000SEC↗
LNSR LENSAR, Inc. A Award2024-05-072024-05-0922,000— $042,573SEC↗
GERN GERON CORP P Buy2023-08-242023-08-246,579$2.28 $15.0K26,220SEC↗
GERN GERON CORP P Buy2023-08-242023-08-246,607$2.28 $15.1K7,407SEC↗
GERN GERON CORP A Award deriv2023-05-312023-06-02125,000— $0125,000SEC↗
LNSR LENSAR, Inc. A Award deriv2023-05-252023-05-3033,175— $033,175SEC↗
LNSR LENSAR, Inc. A Award2023-05-252023-05-309,288— $020,573SEC↗
IKT Inhibikase Therapeutics, I A Award deriv2022-06-242022-06-2840,000— $040,000SEC↗
LNSR LENSAR, Inc. A Award deriv2022-05-252022-05-2715,616— $015,616SEC↗
LNSR LENSAR, Inc. A Award2022-05-252022-05-274,285— $011,285SEC↗
GERN GERON CORP A Award deriv2022-05-102022-05-11125,000— $0125,000SEC↗
IKT Inhibikase Therapeutics, I A Award deriv2021-06-252021-06-2922,677— $022,677SEC↗
LNSR LENSAR, Inc. A Award deriv2021-05-182021-05-2020,847— $020,847SEC↗
GERN GERON CORP A Award deriv2021-05-112021-05-1383,000— $083,000SEC↗
LNSR LENSAR, Inc. A Award deriv2021-03-122021-03-1613,445— $013,445SEC↗
LNSR LENSAR, Inc. A Award deriv2021-02-012021-02-0228,249— $028,249SEC↗
IKT Inhibikase Therapeutics, I A Award deriv2020-12-222020-12-296,825— $06,825SEC↗
PDLI PDL BIOPHARMA, INC. S Sale2020-11-232020-11-2425,826$2.44 $63.0K0SEC↗
PDLI PDL BIOPHARMA, INC. S Sale2020-11-182020-11-2063,291$2.38 $150.6K25,826SEC↗
GERN GERON CORP P Buy2020-08-212020-08-2417,441$1.73 $30.2K19,641SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2020-08-192020-08-24118,671$3.63 $430.8K118,671SEC↗
PDLI PDL BIOPHARMA, INC. A Award2020-08-192020-08-2425,826— $089,117SEC↗
GERN GERON CORP A Award deriv2020-06-052020-06-0983,000— $083,000SEC↗
GERN GERON CORP P Buy2020-01-102020-01-13800$1.35 $1.1K800SEC↗
GERN GERON CORP P Buy2020-01-102020-01-132,200$1.34 $2.9K2,200SEC↗
PDLI PDL BIOPHARMA, INC. A Award deriv2019-06-202019-06-24126,050$3.00 $378.1K126,050SEC↗
GERN GERON CORP A Award deriv2019-06-062019-06-0770,000— $070,000SEC↗
GERN GERON CORP A Award deriv2019-03-262019-03-28120,000— $0120,000SEC↗
PDLI PDL BIOPHARMA, INC. A Award2018-06-222018-06-2563,291$2.37 $150.0K63,291SEC↗